ArticleThe Lancet. Oncology2022
Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma.
Shuvadeep Ganguly et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleThe Lancet. Oncology2022
Shuvadeep Ganguly et al.PubMed ↗Publisher ↗
No numbers read from the abstract.